Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Mitteilungen Klosterneuburg

Melatonin and Virus induced Oncogenic Factors

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSeung Chan Kim

Discussion

Loading...

Member takes

Overview

Observational analysis indicates melatonin may enhance immune response and reduce tumor incidence, suggesting its potential in oncology.

Key Points

  • Melatonin directly inhibits cancer cell proliferation, impacting key signaling pathways involved in tumor growth and metastasis.
  • Research demonstrates melatonin enhances the efficacy of chemotherapy, potentially decreasing the side effects experienced by patients.
  • The hormone exhibits anti-tumor effects, contributing to immune system modulation and overall patient health during cancer treatments.
  • Recent studies explore melatonin's multifaceted role in oncology, offering insight into its therapeutic potential against viral-induced tumor development.

Cite This Study

Seung Chan Kim (2025) studied this question.

synapsesocial.com/papers/68dd9537fe798ba2fc4996ffhttps://doi.org/10.61586/vjqea
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Melatonin: a natural guardian in cancer treatment2025
  2. 2Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy2026
  3. 3Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies2025
  4. 4Melatonin as an anti-inflammatory hormone bridging migraine relief and cancer immunity enhancement: a literature review2025
  5. 5Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications2025